Gilead, Galapagos claim PhIIb/III win for filgotinib in ulcerative colitis — which pales in comparison to rivals
Inovio Pops Almost 10% on ‘Positive’ Preclinical Results For Its Covid-19 Vaccine
Revance Acquires HintMD In All-Stock Deal, Analyst Praises Bold Step Forward
Aldeyra Explodes 30% After-Hours Ahead Of Covid-19 Update Today
MannKind Could Nearly Double in the Next Year, Says Analyst
Menlo Therapeutics is a Must-Watch Ahead of June PDUFA Date, Says Analyst
Cassava Sciences (SAVA): Let’s Shed Some Light on That Crash
Prellis Bio’s Externalized Human Immune System rapidly generates 300 SARS-CoV2 antibodies
Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process
COVID-19 prevention trial opens for high-risk healthcare workers
Modified clinical trial protocol created in response to urgency of COVID-19 pandemic
NEJM Group releases COVID-19 Rx for interactive learning
X-ray experiments zero in on COVID-19 antibodies
Strengthen insolvency frameworks to save firms and boost economic recovery
Fight COVID-19 Deaths With Personal Responsibility
Machine that oxygenates blood may help critically ill COVID-19 patients, according to WVU study
2 Biotech Stocks Under $5 With Blockbuster Potential
Global study to test malaria drug to protect health workers from COVID-19
Covid-19 roundup: Kate Bingham to lead UK taskforce; Federal judge to Shkreli: You’re not going to save the world, stay in prison
2 'Strong Buy' Penny Stocks With Blockbuster Potential
Europe Could Conditionally Approve Gilead’s Remdesivir In Next Few Days
Will PMIs Show Economies Hit Bottom? Are US-China Tensions Rising Again?
Brazilian startup develops technology for monitoring of patients with suspected COVID-19
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Using telehealth to transition diabetes inpatients to virtual care during COVID-19
UHN-U of T-led study shows antiviral drug can speed up recovery of COVID-19 patient
Analyst Places a Long-Shot Bet on Pluristem (PSTI) Stock
Cherry Thomas joins Caribou as SVP of clinical development; Artax locks in Joseph Lobacki as CEO
Palatin Stock Could Soar by Over 300% in the Next Year, Says Top Analyst
Inovio (INO) Offers More Than Just a COVID-19 Vaccine, Says Top Analyst